© 1994 Oxford University Press
other |
Activation of H-ras is prevalent in 1,3-butadiene-induced and spontaneously occurring murine Harderian gland tumors
1Fox Chase Cancer Center Philadelphia, PA 19090
2Merck Research Laboratories West Point, PA 19486
3Cancer Research Institute, St Mary's Hospital and Medical Center Grand Junction, CO 81501
4NIEHS Research Triangle Park NC 27709, USA
5To whom correspondence should be addressed
Treatment of B6C3F1 mice with concentrations of 62.5625 p.p.m. 1,3-butadiene by inhalation for up to 2 years causes a significantly increased incidence of Harderian gland (HG) neoplasms over untreated controls (Melnick,R.,Huff, J., Chou,B.J. and Miller,R.A. Cancer Res., 50, 65926599, 1990). Since a specific K-ras mutation (codon 13 GGC
CGC) had previously been described in lung and liver tumors from 1, 3-butadiene-treated B6C3F1 mice, we analyzed 23 adenomas and sis adenocarcinomas of the HG from mice exposed to 1,3-butadiene for this mutation and mutations in the H-ras gene. We also examined ras activation in 16 spontaneously occurring HG adenomas and one adenocarcinoma. DNA samples were prepared from paraffin-embedded tissues and analyzed by PCR followed by direct sequencing methods. Only one 1,3-butadiene-induced HG tumor contained the K-ras codon 13 mutation previously detected in lung and liver tumors. However, 16/29 HG tumors from the treated B6C3F1 mice contained H-ras codon 61 mutations. The mutations detected were: 12 CAA
CGA transitions, two CAA
CTA and two CAA
AAA transversions. Eleven of 17 spontaneous HG tumors contained mutations in H-ras codon 61: five CA
CGA transitions, two CAA
CTA transversions and four CAA
AAA transversions. While the spectrum of ras mutations did not differ between the spontaneously occurring and chemically induced tumors, these data indicate that activation of H-ras contributes to the process of HG tumorigenesis in both groups of these neoplasms.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H.-H. L. Hong, C. D. Houle, T.-V. T. Ton, and R. C. Sills K-ras Mutations in Lung Tumors and Tumors from Other Organs are Consistent with a Common Mechanism of Ethylene Oxide Tumorigenesis in the B6C3F1 Mouse Toxicol Pathol, January 1, 2007; 35(1): 81 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Houle, T.-V. T. Ton, N. Clayton, J. Huff, H.-H. L. Hong, and R. C. Sills Frequent p53 and H-ras Mutations in Benzene- and Ethylene Oxide-Induced Mammary Gland Carcinomas from B6C3F1 Mice Toxicol Pathol, October 1, 2006; 34(6): 752 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. L. Hong, T. R. Devereux, R. L. Melnick, C. R. Moomaw, G. A. Boorman, and R. C. Sills Mutations of ras Protooncogenes and p53 Tumor Suppressor Gene in Cardiac Hemangiosarcomas from B6C3F1 Mice Exposed to 1,3-Butadiene for 2 Years Toxicol Pathol, July 1, 2000; 28(4): 529 - 534. [Abstract] [PDF] |
||||
![]() |
R.C. Sills, H.L. Hong, R.L. Melnick, G.A. Boorman, and T.R. Devereux High frequency of codon 61 K-ras A->T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene Carcinogenesis, April 1, 1999; 20(4): 657 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Dunnick, J. F. Hardisty, R. A. Herbert, J. C. Seely, E. M. Furedi-Machacek, J. F. Foley, G. D. Lacks, S. Stasiewicz, and J. E. French Phenolphthalein Induces Thymic Lymphomas Accompanied by Loss of the p53 Wild Type Allele in Heterozygous p53-Deficient ({+/-}) Mice Toxicol Pathol, November 1, 1997; 25(6): 533 - 540. [Abstract] [PDF] |
||||

